Carlyle joins $221m round for Japan's Spiber
The Carlyle Group’s Japan team has completed its first minority deal, participating as a cornerstone investor in a JPY24.4 billion ($221 million) round for local biomaterials developer Spiber.
It demonstrates a developing tendency among traditional buyout firms operating in Asia to embrace minority growth strategies amid a mix of incentives such as rising competition for assets, higher valuations,...
More on North Asia
Latest News
Bain targets $102m Japan advertising take-private
Bain Capital has won board approval from Net Marketing, a Tokyo-listed online advertising and media management business, for a take-private that values the company at approximately JPY 13.6bn (USD 102m).
China's Insilico Medicine gets another $35m
Insilico Medicine, a China-based artificial intelligence-driven drug discovery company, has closed the second tranche of its Series D round on USD 35m, with Prosperity7 Ventures taking the lead.
Singapore crypto risk platform extends Series A to $24m
Singapore’s Merkle Science, a predictive crypto analytics platform, has raised USD 24m in Series A funding led by K3 Ventures, Darrow Holdings, and Beco Capital.
Cartesian seals deal for China rollout of restaurant chain Popeyes
Cartesian Capital Group, a US private equity firm that has served as Restaurant Brands International’s (RBI) joint venture partner for Burger King in China for the past decade, has been awarded exclusive country development rights for the company’s...